Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report
Braz. j. infect. dis
;
13(2): 158-160, Apr. 2009.
Article
in English
| LILACS
| ID: lil-538225
ABSTRACT
Multidrug therapy (WHO/MDT) in multibacillary leprosy consists of treatment with rifampicin, dapsone andclofazimine. However, adverse effects can cause the patient to abandon treatment. We report on a patient whopresented agranulocytosis and hemolytic anemia associated with this treatment regime. We also examined theimportance of laboratory exams for diagnosis and follow-up of the patient, and for early detection of adverse effects, with a view to improving adhesion to treatment and contributing to the eradication of Hansens disease as a public health issue.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Agranulocytosis
/
Anemia, Hemolytic
/
Leprostatic Agents
Type of study:
Screening study
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
Braz. j. infect. dis
Journal subject:
Communicable Diseases
Year:
2009
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Federal University of Paraíba/BR
/
Medicine School Nova Esperança/BR
Similar
MEDLINE
...
LILACS
LIS